Our data confirmed that in conditions such as diabetes this angiogenic balance is altered in a manner that is consistent with an over-production of the TSP and PEDF angiostatic factors and a downregulation of VEGF expression. The gene discussed is SERPINF1; the disease is diabetes mellitus.